P358 Risk of incident cancer in patients with inflammatory bowel disease starting anti-TNF therapy while having prior malignancy within past 5 years (GETAID survey) | Zendy

AI Assistant Blog Pricing

P358 Risk of incident cancer in patients with inflammatory bowel disease starting anti-TNF therapy while having prior malignancy within past 5 years (GETAID survey)

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.